ADAR1 Capital Management, LLC

Position in CNTX — Context Therapeutics Inc.

CIK 1940272 AUSTIN, TX

Position in CNTX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$416,036

-$503,830 QoQ

Shares Held

750,969

+113.9% QoQ

Ownership

0.817%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#16

of 79 holders

Holding Since

Mar 2024

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

ADAR1 Capital Management, LLC holds $1,760,528,411 across 192 Biotechnology names. CNTX ranks #157 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABVX	Abivax S.A.	1,804,703	$240,494,721
2	PTGX	Protagonist Therapeutics, Inc	960,863	$117,782,586
3	ROIV	Roivant Sciences Ltd.	3,157,008	$111,726,513
4	IMVT	Immunovant, Inc.	2,330,716	$89,802,487
5	ZLAB	Zai Lab Ltd	3,369,034	$64,011,646
6	AGIO	Agios Pharmaceuticals, Inc.	1,288,053	$47,799,646
7	CRNX	Crinetics Pharmaceuticals, Inc.	1,222,080	$45,730,233
8	CYTK	Cytokinetics Inc	457,907	$39,009,097

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$416,036	750,969	+113.9%	Shares	Sole	2026-08-14
2026-03-31	$919,866	351,094	0.0%	Shares	Sole	2026-05-18
2025-12-31	$516,108	351,094	0.0%	Shares	Sole	2026-02-18
2025-09-30	$340,210	351,094	0.0%	Shares	Sole	2025-11-14
2025-06-30	$229,966	351,094	0.0%	Shares	Sole	2025-08-14
2025-03-31	$214,869	351,094	0.0%	Shares	Sole	2025-05-15
2024-12-31	$368,648	351,094	-6.1%	Shares	Sole	2025-02-13
2024-09-30	$732,716	373,835	-42.1%	Shares	Sole	2024-11-14
2024-06-30	$1,293,547	645,161	+213.3%	Shares	Sole	2024-08-13
2024-03-31	$284,188	205,934	—	Shares	Sole	2024-05-15
No filing history on record for this holder in this stock.